1 / 12

Developing a local guideline for the management of cow’s milk protein intolerance

Developing a local guideline for the management of cow’s milk protein intolerance. GP Study day 9 th June 2010. Overview. Why develop a local guideline? Diagnosis of CMPA Symptoms of CMPA Managing CMPA in primary care Managing CMPA in secondary care Controversies in guideline development

reya
Download Presentation

Developing a local guideline for the management of cow’s milk protein intolerance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Developing a local guideline for the management of cow’s milk protein intolerance GP Study day 9th June 2010

  2. Overview • Why develop a local guideline? • Diagnosis of CMPA • Symptoms of CMPA • Managing CMPA in primary care • Managing CMPA in secondary care • Controversies in guideline development • Discussion

  3. Why develop a local guideline • No widely accepted, national guidelines • Significant problem (2-3% babies) • Some confusion (eg with lactose intolerance) • Wide variety in current practice • Often crosses professional boundaries • Better evidence base than for many other treatments that are currently recommended eg for “colick”

  4. Diagnosing CMPA • Can be a challenge • Symptoms often non-specific, • difficult to quantify objectively • Symptoms: • should be consistent and related to feeds • typically within first month of life or within 1 week of switching to formula feed • Often affect more than one body system • History/family history of atopy increase likelihood but not diagnostic

  5. Physiology • IgE mediated (SPT/RAST) Urticaria, swelling, wheezing, vomiting, anaphylactic symptoms Immediate Can be life threatening • Non IgE mediated – at least 50% (no tests available) Gut or skin symptoms more likely Delayed Is there a role for allergy tests?

  6. Symptoms of CMPA

  7. Diagnosing CMPA in primary care • Red flags? • Positive history • Exclusion diet for 2 – 4 weeks • Bottle-fed : extensively hydrolysed formula • Breast fed : maternal diary free diet (with calcium supps) • Rechallenge with CMPA after 4 weeks • No role for “allergy tests”

  8. Management of CMPA in primary care • Proven when symptoms resolve on CMP-free diet and recur on challenge. • Restart CMP-free diet for 6 months or until aged 1 year (whichever later). • Refer to paed dietitians for weaning advice • Rechallenge with CMP at 12 months of age and every 6 months until passes or aged 3 • Refer to paeds if persistent symptoms aged 3yrs

  9. Management of CMPA in secondary care • Likely to be more severe cases – eg faltering growth, blood in stools, severe reflux • Includes those not responding to primary care management • SPT/RAST? • Go straight for amino-acid based formula (eg neocate). • Do not re-challenge after 4 weeks • Consider alternative diagnosis if not improving

  10. Controversies in developing guideline • Extensively-hydrolysed or amino acid based? • Evidence is that 10% pts will not tolerate EHF and will need amino acid feed • If severe symptoms this rises to 50% • Agreed that EHF appropriate (& cheaper) for those managed in primary care, amino acid feeds for those requiring secondary care • Any role for partially hydrolysed formula?

  11. Controversies in developing guideline • Re-challenge at 4 weeks or not? • Some suggest re-challenge, others say not, others say try EHF rather than amino acid feed • Agreed to re-challenge in primary care where more likely to be “temporary” feed issues which resolve with time rather than treatment. • Not to re-challenge in secondary care as more likely to have significant symptoms and re-challenge more harmful (& harder to sell to parents) • Role of SPT/RAST?

  12. Discussion Thoughts and comments welcome

More Related